Sanofi to explore acquisition of cancer drugmaker Mirati- Bloomberg News
(Reuters) – Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the matter. Deliberations are ongoing and…